Monographie - Levofolinate calcium

Ultimele actualizari :
19/11/2024

Levofolinate calcium

Formula chimica

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Calc Levof	Italia
Calcium levofolinat	Austria
Elvorine	Belgia, Franta, Luxemburg, Maroc
Folaxin	Spania
Folinate EG	Belgia
Isovorin	Austria, Danemarca, Finlanda, Grecia, Islanda, Marea Britanie, Spania, Suedia
Levofolatino de calcio	Portugalia
Levofolene	Italia

Bibliografie : Levofolinate calcium

	tip	publicare
3	ziar	Trissel LA, Martinez JF. Compatibility of amifostine with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
155	ziar	Trissel LA, Martinez JF, Xu QA. Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium. Am J Health-Syst Pharm 1995 ; 52: 710-715.
1520	Laborator	Etude de stabilité des médicaments en Ecoflac® B Braun 2001
1914	Laborator	Pemetrexed (Alimta®) - Summary of Product Characteristics Eli Lilly 2016
2130	ziar	Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J. Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique. Bull Cancer 1999 ; 86, 11: 946-954.
2181	ziar	Milano G, Renée N. Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique. Bull Cancer 1995 ; 82: 189-195.
2295	Laborator	Fosaprepitant (Emend®) - Summary of Product Characteristics Merck Sharp Dohme 2013
2361	ziar	Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L. Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags. J Clin Pharm Ther 2009 ; 34, 4 : 423-428.
2531	ziar	Sanogo S, Silimbani P, Gaggeri R, Masini C. Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags. J Oncol Pharm Practice 2021 ; 27, 2: 288-296.
3369	Laborator	Levofolinate de sodium Medac - Résumé des caractéristiques du produits MEDAC France 2011
3523	Laborator	Ceftriaxone (Rocephin®) - Summary of Product Characteristics. Roche 2018
3546	Laborator	Cefamandole Flavelab - Résumé des caractéristiques du produit Panpharma SA 2007
3619	Laborator	Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics Wockhardt 2016
3621	Laborator	Phosphate dipotassique - Résumé des caractéristiques du produit Renaudin 2008
3662	Laborator	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014
3753	Laborator	Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics Cubist Pharmaceuticals 2014
3838	Laborator	Magnesium Sulphate - Summary of Product Characteristics Martindale Pharmaceuticals Ltd 2007
3933	Laborator	Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit Teva Laboratoire 2015
4154	Laborator	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4720	Laborator	Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021. Paratek Pharmaceuticals 2021

Mentions Légales